HCV-Flavi 2026

Grant number: cf25-2214

Grant search

Key facts

  • Disease

    Unspecified
  • Start & end year

    2026
  • Known Financial Commitments (USD)

    $12,586.4
  • Funder

    Carlsberg Foundation
  • Principal Investigator

    Associate Professor Troels Scheel
  • Research Location

    Denmark
  • Lead Research Institution

    University of Copenhagen
  • Research Priority Alignment

    N/A
  • Research Category

    14
  • Research Subcategory

    N/A
  • Special Interest Tags

    N/A
  • Study Type

    Unspecified
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Unspecified
  • Vulnerable Population

    Unspecified
  • Occupations of Interest

    Unspecified

Abstract

Name of applicant Troels Scheel Title Associate Professor Institution University of Copenhagen Amount DKK 80,000 Year 2026 Type of grant Conferences Over 30 years, the HCV-Flavi meeting series has helped turn hepatitis C from a fatal into a curable disease. The 2026 meeting expands the scope to viruses like Zika, dengue and tick-borne encephalitis, which are spreading due to climate change. By gathering the world's brightest minds, we aim to accelerate basic understanding of infection biology leading to novel vaccines and therapeutics.